ABRAMSON, B. L.; NELSON, S. M. PCSK9 Targeted Therapy to Lower Cholesterol and Reduce Cardiovascular Events. Canadian Cardiology Today, Toronto, Canada, v. 1, n. 1, p. 20–25, 2025. DOI: 10.58931/cct.2025.114. Disponível em: https://canadiancardiologytoday.com/article/view/1-1-Abramson_et_al. Acesso em: 4 apr. 2025.